3B级滤泡性淋巴瘤的诊断与治疗挑战
3B级滤泡性淋巴瘤仅占滤泡性淋巴瘤的5-10%,常被排除在临床试验之外,诊断、预后、治疗选择和影像学作用的数据相互矛盾。随着低级别滤泡性淋巴瘤治疗选择增多及高级别B细胞淋巴瘤分子分型进展,G3B FL的特征和治疗愈发重要。本综述总结并评价关于G3B FL遗传特征、PET影像特征、治疗选择及结局的新数据,并基于当前证据提出建议。
要点
- G3B FL仅占FL的5-10%,常被排除在临床试验外。
- 诊断、结局、治疗选择和影像学作用的数据存在矛盾。
- 新数据探索了G3B FL的独特遗传特征和PET影像特征。
核心结论
- G3B FL因罕见且常被排除在临床试验外,其诊断和治疗面临挑战,需基于新证据重新评估。
研究设计与样本
- 本文为综述,总结并评价关于G3B FL诊断、结局、治疗选择和影像学作用的新数据。
主要发现
- G3B FL仅占FLs的5-10%。
- G3B FL常被排除在临床试验之外,已发表数据相互矛盾。
- 新数据探索了G3B FL的独特遗传特征和PET影像特定特征。
临床怎么用
- 基于当前证据对G3B FL的诊断和治疗提出建议。
局限性
- G3B FL罕见且常被排除在临床试验外,已发表数据相互矛盾。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Grade 3B follicular lymphoma (G3B FL) is rare, accounting for only 5-10% of FLs. Not only has it been routinely excluded from clinical trials, but data published on diagnosis, outcomes, choice of therapies and role of imaging are conflicting. With the advent of increasingly diverse treatment options for low-grade (G1-3A) FL, and the molecular subcategorisation of high-grade B-cell lymphomas, characterisation and treatment of G3B FL is ever more important as extrapolation of data becomes more difficult. New data have emerged exploring unique genetic characteristics, specific features on positron emission tomography imaging, choice of therapy, and outcomes of G3B FL in the current era. The present review will summarise and appraise these new data, and offer recommendations based on current evidence.
引用
- Barraclough A, Bishton M, Cheah CY, et al. The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma. Br J Haematol. 2021. PMID: 33704790. doi:10.1111/bjh.17404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。